Whether you’re working on biologics such as monoclonal antibodies, recombinant proteins or peptides, vaccines, oligonucleotides or gene therapies, the regulatory requirements are explicit – the biological activity or potency of a biopharmaceutical product must be established as a critical quality attribute (CQA).
The challenge is related to the complexity in designing, optimising, and executing them. They involve living systems, nuanced method development, and require highly skilled analysts capable of consistently managing variable biological systems.
With decades of proven expertise, the Eurofins BioPharma Product Testing network of laboratories provides comprehensive support across all phases of product development, delivering robust, regulatory-aligned biological assays—validated and tailored to each product profile, development timeline, and strategic objectives.
Our full suite of services:
From building client-specific, ad hoc assays to adapting platform methods for novel biologics, our teams are equipped with the regulatory knowledge and scientific expertise required to deliver:
Cell-Based Assays
Binding Assays
Our assay maintenance programmes and continued lifecycle management ensure validated methods remain robust and fit for purpose over time.
If your internal teams need added capacity or expertise to manage this demanding testing, Eurofins BPT provides the kind of end-to-end solution that has resulted in long-lasting client partnerships.